Correction

CDER167, a dual inhibitor of URAT1 and GLUT9, is a novel and potent uricosuric candidate for the treatment of hyperuricemia (vol 43, pg 121, 2022)

Journal

ACTA PHARMACOLOGICA SINICA
Volume 43, Issue 7, Pages 1884-1884

Publisher

NATURE PUBL GROUP
DOI: 10.1038/s41401-022-00872-z

Keywords

-

Funding

  1. National Natural Science Foundation of China [81974507, 81773794]
  2. Science and Technology Program of Guangzhou City, China [201903010087]

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Recommended

No Data Available
No Data Available